This prospective randomised clinical trial aims to assess the impact of intraoperative nociception monitoring using NOL on anesthetic management during major abdominal surgery. Additionally, the study will objectively evaluate using NOL how intravenous lidocaine administration, influences opioid requirements and the effect of this multimodal approach on early postoperative outcomes. The investigators hypothesize that NOL-guided intraoperative opioid administration reduces both intraoperative and postoperative opioid use, positively influencing 24-hour outcomes. Furthermore, the addition of intraoperative lidocaine in NOL-guided analgesia may further decrease opioid consumption.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
160
intravenous lidocaine 10 mg/ml continuous infusion
Intraoperative Nociception Level index monitoring and guided analgesia
Regional Gastroenterology and Hepatology Institute Octavian Fodor
Cluj-Napoca, Cluj, Romania
RECRUITINGIntraoperative opioid use
We aim to examine the effect nociception level index monitoring in major abdominal surgery on intraoperative nociception management by measuring total opioid use in NOL monitored patients vs standard care according to the anesthesiologists judgement. Moreover, crossreference interventional arms will examine the effect of intraoperative administration of lidocaine in NOL and no NOL groups on intraoperative opioid use. Intraoperative opioid use will be time adjusted ( depending on the duration of surgery) and weight adjusted (depending on the weight of the patient)- mg of opioid/hour/kg
Time frame: intraoperative
Intraoperative pulse
Mean pulse rate and peak pulse rate
Time frame: intraoperative
Intraoperative blood pressure
Mean blood pressure and peak blood pressure
Time frame: intraoperative
Postoperative pain scores
VAS score at 15 minutes, 30 minute, 2 hours 4 hours, 12 hours and 24 hours
Time frame: 24 hours
Postoperative opioid use
Time frame: 24 hours
Lidocaine related adverse events
Time frame: 24 hours
Opioid related adverse events
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.